Absorbable Hydrogel Spacer
Customize your policy alerts
Sign up for Geisinger Health Plan Policy MP320 alerts
Get alerted when Policy MP320 changes without checking for updates manually.
Monitor payer policy activity
Policy governing coverage of FDA‑approved absorbable rectal hydrogel spacers (e.g., SpaceOAR) to reduce rectal and urinary toxicity for men undergoing radiotherapy for prostate cancer; applies to Geisinger Health Plan lines of business per member benefit documents.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.